A

Correction: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2

Genetics in Medicine, vol. 22, pp. 1427–1428

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Authors 7

  1. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

  2. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

  3. Hospital Clínico San Carlos · Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

    Affiliation as printed

    Molecular Oncology Laboratory, Instituto de Investigacion Sanitaria San Carlos, Hospital Clinico San Carlos, Madrid, Spain

  4. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

    Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

  5. Leiden University Medical Center

    Affiliation as printed

    Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands

  6. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

  7. Leiden University Medical Center

    Affiliation as printed

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. Vreeswijk@lumc.nl

    Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 0